Optic Nerve Atrophy (ONA) is a progressive ocular condition in which the optic nerve – responsible for transmitting visual information from the eye to the brain – undergoes degeneration. This damage leads to gradual vision loss and, in severe cases, complete blindness. ONA is not a disease itself but a final stage of various underlying pathologies such as glaucoma, optic neuritis, ischemia, trauma, inflammation, or inherited disorders like Leber's hereditary optic neuropathy. [1]
According to the Global Burden of Disease Study [2], vision impairment affects over 1.2 billion people worldwide, and in regions like England and Wales, optic atrophy accounts for approximately 14% of new-onset blindness cases among working-age adults. [3] The impact of this condition on quality of life is significant, especially because ONA is often irreversible.
Traditional treatments aim only to slow progression or manage symptoms – they rarely lead to vision restoration. However, recent advancements in regenerative medicine have introduced a new treatment for optic nerve atrophy: stem cell therapy. This innovative approach targets nerve repair and functional improvement, improving outcomes where conventional therapies fall short. [4]
If you or your loved one has been diagnosed with ONA, do not lose hope. Recovery – especially partial visual restoration and improved function – is now possible. Early intervention and access to advanced treatments may transform what was once a life-altering diagnosis into a manageable condition.
Understanding Optic Nerve Atrophy
As mentioned above, ONA refers to the degeneration of the optic nerve fibers, most commonly caused by damage to the retinal ganglion cell axons, which disrupts the transmission of visual signals from the retina to the brain. This degeneration results in permanent nerve damage and vision loss. [1]
Types of Optic Atrophy
ONA can be categorized based on its underlying causes [1]:
- Primary optic atrophy – Occurs without any prior swelling of the optic disc, often linked to hereditary conditions or trauma.
- Secondary optic atrophy – Follows optic disc swelling due to inflammation (e.g., optic neuritis), increased intracranial pressure, or ischemia.
- Consecutive optic atrophy – Associated with retinal diseases or degeneration, such as retinitis pigmentosa.
- Acute causes, such as traumatic injury or sudden ischemic events, may also lead to rapid optic nerve degeneration, requiring urgent evaluation.
Symptoms
Patients with optic atrophy often report [1]:
- Blurred or reduced visual acuity
- Pale appearance of the optic disc on fundoscopic exam
- Decreased color vision
- Central or peripheral visual field defects
Diagnostic Tools
Early and accurate diagnosis is crucial and typically involves [1]:
- Optical Coherence Tomography (OCT) – Measures retinal nerve fiber thickness
- Visual Field Testing – Detects blind spots or visual field constriction
- Visual Evoked Potentials (VEP) – Evaluates the functional integrity of the optic nerve pathways
What Is Stem Cell Therapy?
Stem cell therapy is an innovative treatment for optic nerve damage that aims to repair or replace damaged tissues by utilizing the body's natural healing potential. It involves the use of autologous (from the patient's own body) or allogeneic (donor-derived) stem cells that have not yet differentiated into specific tissue types. These cells can self-renew, reduce inflammation, stimulate repair processes, and even support mitochondrial function – making them a promising approach for treating ONA. [4]
According to Dr. Siebenhüner, a leading specialist in this field with over 40 years of medical experience, "Tissues that have lost their normal functions can be restored with stem cells." He notes that stem cell therapy does not necessarily replace damaged cells but can reactivate the patient's own underperforming nerve cells, significantly improving neurological functions – including vision in some patients.
In patients with ONA, stem cells are not injected directly into the optic nerve but rather into the surrounding area. These cells, aided by magnetic guidance, migrate to areas of injury or inflammation. Once there, they initiate neuroprotective and regenerative processes that can enhance optic nerve function and slow degeneration.
Several types of stem cells are used in clinical settings for optic nerve conditions, including [4]:
- Mesenchymal Stem Cells (MSCs) – derived from bone marrow, fat, or umbilical cord
- Neural Stem Cells (NSCs) – precursors to neurons and glial cells
- Umbilical Cord Stem Cells – known for their high plasticity and low rejection rate
Dr. Siebenhüner on Advanced Stem Cell Treatment: From Joint Recovery to Brain Regeneration
How Stem Cell Therapy Works for Optic Nerve Damage
Stem cell therapy offers a pathway for patients with chronic or progressive optic nerve damage, particularly those who still retain partial vision. This advanced form of treatment is primarily aimed at neuroprotection, immune modulation, and neural repair – goals that traditional medications cannot achieve. [4]
Patients who are considered suitable candidates for this optic nerve atrophy treatment often include those with [4]:
- Partial vision loss (as total optic nerve destruction cannot be reversed)
- Chronic cases of optic nerve atrophy
- Progressive degeneration due to glaucoma, ischemia, trauma, or inherited conditions
The most common administration methods of stem cell therapy for optic nerve damage include [4]:
- Retrobulbar injection (around the eye to reach the optic nerve region)
- Intravenous infusion (for systemic immune and inflammatory regulation)
- Intrathecal injection (into the spinal fluid, used in certain protocols for broader neural effects)
Once introduced into the body, stem cells home in on damaged tissues. Their effects include [4]:
- Immune modulation – reducing harmful autoimmune activity
- Inflammation reduction – creating a more favorable healing environment
- Neural regeneration – stimulating the growth of axons and supporting cell survival
Clinical studies show encouraging outcomes. For example, a 2024 meta-analysis [4] reported that MSC therapy significantly improved mean visual acuity (LogMAR score from 0.90 to 0.65, p = 0.001), with many patients showing measurable gains within six months. In addition, a 2019 clinical trial [5] involving suprachoroidal implantation of adipose-derived MSCs showed consistent improvements in visual acuity, visual field, and mfERG in all patients by month six. These results suggest that, when administered early enough, stem cells can significantly slow or even reverse vision deterioration, especially in patients whose optic nerve retains partial functionality.
What to Expect: Benefits of Stem Cell Treatment for ONA
Stem cell therapy is increasingly recognized as a transformative option for patients seeking treatment for optic atrophy. Main benefits observed include [4, 5]:
- Slowed or halted progression of vision loss by protecting remaining nerve fibers
- Improved central vision and color perception, often reported within 3-6 months post-treatment
- Functional restoration of the optic nerve, as stem cells promote the repair and survival of damaged axons
- Enhanced quality of life through improved mobility, reading ability, and daily independence
It is necessary to note that even partial visual recovery can have major life-changing effects. Many patients report reduced dependence on caregivers, greater confidence in navigating their environment, and the ability to resume work or hobbies previously abandoned due to vision impairment. [4, 5]
Although stem cell therapy is not a cure, it offers potential functional restoration in cases once deemed untreatable. For individuals living with ONA, it represents a new strategy in eye atrophy treatment and long-term neuroregeneration.
Potential Limitations and Side Effects
While stem cell therapy for ONA offers exciting possibilities, it is important to understand its limitations and risks. This treatment of optic atrophy is not suitable for patients with total vision loss, as completely dead optic nerve axons cannot regenerate. The therapy is most effective in cases where some viable nerve tissue remains.
Potential risks include:
- Infection at the injection site
- Immune response or graft rejection (more common with allogeneic transplants)
- Localized inflammation following the procedure
- Lack of guaranteed outcomes, as not all patients respond to treatment
Despite these risks, the safety profile of stem cell therapy has been generally favorable. Clinical trials and case reports indicate that most patients tolerate the procedure well, particularly when autologous cells are used. [4, 5] However, it is important to mention that stem cell therapy for ONA is still considered experimental in many countries and is not yet part of standard treatment protocols.
Comparative Table: Stem Cells vs. Traditional Treatments
When evaluating optic atrophy treatment options, it is essential to compare traditional approaches with the regenerative potential of stem cell therapy. While conventional therapies aim to slow progression or manage symptoms, stem cell therapy targets the root cause: nerve damage.
| Parameter | Stem Cell Therapy | Traditional Treatment |
|---|---|---|
| Mechanism | Regeneration | Symptom management |
| Target | Nerve repair | Pressure control, antioxidants |
| Vision Restoration | Possible (partial cases) | Unlikely |
| Duration of Effect | Long-term | Temporary |
| Cost (avg.)* | From €20,790 | €3,000-€10,000 |
* Treatment prices are approximate and may vary depending on the clinic, the patient's medical condition, the number of injections required, and the complexity of the diagnostic program.
As evident, stem cell therapy requires a larger upfront investment. However, it may offer a longer-lasting functional outcome, especially in early to moderate stages of optic nerve degeneration.
Sofia's Experience with Stem Cell Therapy for ONA
Sofia, a young woman diagnosed with ONA caused by optic neuritis, faced progressive vision loss in her left eye. Over time, the degeneration significantly affected her daily life and sense of independence. Conventional treatments failed to improve her condition, and her doctors told her that no further recovery was likely. Refusing to accept this outcome, she began searching for alternative options and discovered optic nerve atrophy stem cell treatment through Booking Health.
Sofia underwent a personalized treatment plan in Germany that included MSCs delivered via retrobulbar (around the eye) and intravenous injections. Within three months, she began noticing improvements in light sensitivity and peripheral vision. Her ophthalmologist confirmed that the optic nerve was more responsive and stable than before.
"I became more confident and happy. Now I can go out alone, recognize people's faces again, and I don't feel helpless anymore," she shared.
She emphasized the professionalism of the German medical team, the comfort of the clinic environment, and the attentive support provided by Booking Health – which handled everything from her medical visa and interpreter to appointment scheduling.
Sofia also pointed out how comfortable and painless the procedure was. She had no serious side effects and only mild temporary fatigue. Today, she urges others not to give up:
"Don't be afraid. Fight for your health. I'm living proof that even after vision loss, improvement is possible."
Watch Sofia's full story here:
Where to Get Treatment and What It Costs
A diagnosis like ONA can feel devastating and disorienting. When your vision fades and doctors say, "there is nothing more we can do," it can feel like the end. However, even when options appear limited, there is always hope – especially in an age where medicine is evolving faster than ever.
Medical innovation continues to push boundaries: innovative therapies, advanced imaging tools, and regenerative medicine are reshaping what is possible. Traditional approaches, such as vitamins, corticosteroids, and pressure-lowering medications, have been used for decades – but they often come with limitations, managing symptoms rather than restoring function. For many patients, they simply do not work.
That is when a second wind arrives – through stem cell therapy. This advanced treatment offers new potential for optic nerve recovery. It does not require weeks in a hospital or a lifetime of pills. In many cases, it involves just a few sessions with minimal side effects, aiming to protect and regenerate the damaged optic nerve.
These innovative treatments are available in the best German clinics, including the Clinic of Advanced Biological Medicine Frankfurt am Main, and are accessible internationally through medical tourism operators such as Booking Health. While advanced, this care is not out of reach. The cost of treatment for optic nerve atrophy with stem cells typically starts at €20,790, depending on the clinic, number of injections, and diagnostic needs.
This price often includes not just the therapy itself, but comprehensive diagnostics, hotel accommodation, medical transfers, and multilingual support – offering a stress-free experience for international patients seeking world-class care.
Stem cell therapy may not yet be a cure, but it is a life-changing intervention – a tool to preserve, protect, and possibly improve vision. Do not give up on the possibility. If you are considering stem cell therapy for ONA in Germany, Booking Health offers a fully supported path to care.
A Medical Journey: Every Step of the Way With Booking Health
Finding the most effective treatment strategy for ONA can feel overwhelming. After countless appointments, inconclusive diagnoses, and limited therapeutic options, you may be emotionally and physically drained. In such moments, it is easy to settle for standard treatments that manage symptoms but offer little hope of recovery. However, innovative approaches – such as regenerative stem cell therapy – are now transforming outcomes for patients previously told nothing more could be done.
To make an informed decision and receive a personalized treatment plan tailored to your unique clinical situation, consult the experts at Booking Health. With over 12 years of experience at the forefront of advanced medical solutions, Booking Health has helped thousands of patients access advanced care, including experimental regenerative therapies for neurodegenerative conditions like ONA. We offer full-service coordination, ensuring you receive world-class care with ease and peace of mind.
We provide:
- Comprehensive assessment and analysis of your medical reports
- Development of an individualized treatment and diagnostics program
- Selection of the most suitable clinic and physician
- Assistance in preparing and forwarding medical documentation
- Pre-treatment consultations with experts in ophthalmology and regenerative medicine
- On-site support and expert advice during your hospital stay
- Follow-up care recommendations for your return home
- Full coordination of travel and stay, including visa and flight support
- A dedicated personal coordinator and interpreter available 24/7
- Transparent budgeting with no hidden costs
Vision is one of our most precious senses. When it begins to fade, finding the right care is crucial. Booking Health is a trusted partner that ensures access to innovative and personalized treatment options – including stem cell therapy – at leading German clinics. We walk beside you every step of the way, helping you pursue better eyesight and an improved quality of life. Contact our medical consultant today to explore your treatment options for optic nerve atrophy.
Stem Cell Therapy: Patient Stories with Booking Health
Frequently Asked Questions About Stem Cell Therapy for Optic Nerve Atrophy (ONA)
Send request for treatmentOptic nerve atrophy is the degeneration of the optic nerve, leading to progressive vision loss due to nerve damage. It can result from trauma, glaucoma, ischemia, inflammation, or genetic disorders.
In cases of partial vision loss, stem cell therapy may improve optic nerve function and visual acuity. Unfortunately, total blindness due to complete nerve death cannot be reversed.
Stem cells reduce inflammation, support nerve regeneration, and restore mitochondrial function, helping damaged optic nerve cells recover functionality.
Yes, the therapy is generally well-tolerated, especially when autologous stem cells are used. Mild inflammation or injection site irritation is possible.
Mesenchymal stem cells (MSCs), neural stem cells (NSCs), and umbilical cord-derived cells are commonly used.
Yes, multiple clinical studies and pilot trials are underway in Germany, China, and the U.S., showing encouraging early results.
Recent studies show that many patients with chronic ONA experience improvements in visual acuity and visual fields after stem cell therapy. Success is most likely when some optic nerve function remains, with measurable gains seen in several trials within six months.
Initial results may appear within 2-3 months, with continued improvement for up to 6 months.
Stem cells stimulate optic nerve regeneration by activating dormant cells and reducing further degeneration, though full regeneration is rare.
Patients with partial vision loss, early to moderate optic atrophy, and stable systemic health are ideal candidates.
Minor risks include injection site irritation, inflammation, and immune reaction (rare with autologous cells). It is considered safe in regulated settings.
The cost of treatment for optic nerve atrophy starts at €20,790, depending on the clinic and treatment protocol.
Top clinics in Germany, such as the Clinic of Advanced Biological Medicine Frankfurt am Main, offer internationally accredited programs.
Choose treatment abroad and you will be sure to get the best results!
Authors:
This article was edited by medical experts, board-certified doctors Dr. Nadezhda Ivanisova, and Dr. Bohdan Mykhalniuk. For the treatment of the conditions referred to in the article, you must consult a doctor; the information in the article is not intended for self-medication!
Our editorial policy, which details our commitment to accuracy and transparency, is available here. Click this link to review our policies.
Sources:
[1] National Library of Medicine. Optic Atrophy. https://www.ncbi.nlm.nih.gov/books/NBK559130/
[2] Lancet Regional Health – Americas. National Sex- and Age-Specific Burden of Blindness and Vision Impairment by Cause in Mexico in 2019: A Secondary Analysis of the Global Burden of Disease Study 2019. https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(23)00126-6/fulltext/
[3] BMJ Open. A Comparison of the Causes of Blindness Certifications in England and Wales in Working Age Adults (16-64 years), 1999-2000 with 2009-2010. https://bmjopen.bmj.com/content/4/2/e004015
[4] BMC Ophthalmology. Evaluating the Impact of Mesenchymal Stem Cell Therapy on Visual Acuity and Retinal Nerve Fiber Layer Thickness in Optic Neuropathy Patients: A Comprehensive Systematic Review and Meta-Analysis. https://bmcophthalmol.biomedcentral.com/articles/10.1186/s12886-024-03588-2
[5] International Ophthalmology. Six-Month Results of Suprachoroidal Adipose Tissue-Derived Mesenchymal Stem Cell Implantation in Patients with Optic Atrophy: A Phase 1/2 Study. https://link.springer.com/article/10.1007/s10792-019-01141-5
Read:
Stem cell treatment in Germany
Не знаете, с чего начать?
Свяжитесь с Booking Health
